Drugs / Artesunate-pyronaridine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07060794 | Jun 2026 → Jun 2028 expected | Plasmodium vivax malaria | Menzies School of Health Research | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Artesunate-pyronaridine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07060794 ↗ |